CLI's future position in the US industrial hemp market

IMO, comparing to other ASX-listed cannabis stocks of similar market cap, CLI has by far the best prospect of becoming cash flow-positive in the next 6 months. Many of these companies on the chart are still trying to keep their heads above water. While others compete in the medical cannabis and CBD nutraceuticals market, CLI could use its expertise in agronomy and the first-mover advantage in the US market to become a primary producer of industrial hemp. In the current macro-economic environment, I would very much prefer to hold onto a company that shows a steady net inflow of cash in their quarterly statements.
The statements above are speculative, please do your own research.